These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 9126242)

  • 1. Prostate-specific membrane antigen and other prostatic tumor markers on the horizon.
    Israeli RS; Grob M; Fair WR
    Urol Clin North Am; 1997 May; 24(2):439-50. PubMed ID: 9126242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostate-specific membrane antigen.
    Fair WR; Israeli RS; Heston WD
    Prostate; 1997 Jul; 32(2):140-8. PubMed ID: 9215402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of prostate specific membrane antigen and three alternatively spliced variants of PSMA in prostate cancer patients.
    Schmittgen TD; Teske S; Vessella RL; True LD; Zakrajsek BA
    Int J Cancer; 2003 Nov; 107(2):323-9. PubMed ID: 12949815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Western blot assay for prostate-specific membrane antigen in serum of prostate cancer patients.
    Rochon YP; Horoszewicz JS; Boynton AL; Holmes EH; Barren RJ; Erickson SJ; Kenny GM; Murphy GP
    Prostate; 1994 Oct; 25(4):219-23. PubMed ID: 8084837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alternatively spliced variants of prostate-specific membrane antigen RNA: ratio of expression as a potential measurement of progression.
    Su SL; Huang IP; Fair WR; Powell CT; Heston WD
    Cancer Res; 1995 Apr; 55(7):1441-3. PubMed ID: 7882349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostate-specific membrane antigen: evidence for the existence of a second related human gene.
    Leek J; Lench N; Maraj B; Bailey A; Carr IM; Andersen S; Cross J; Whelan P; MacLennan KA; Meredith DM
    Br J Cancer; 1995 Sep; 72(3):583-8. PubMed ID: 7669565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of circulating prostate tumor cells: alternative spliced variant of PSM induced false-positive result.
    Hisatomi H; Nagao K; Kawakita M; Matsuda T; Hirata H; Yamamoto S; Nakamoto T; Harasawa H; Kaneko N; Hikiji K; Tsukada Y
    Int J Mol Med; 2002 Nov; 10(5):619-22. PubMed ID: 12373303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization and glutamyl preferring carboxypeptidase function of prostate specific membrane antigen: a novel folate hydrolase.
    Heston WD
    Urology; 1997 Mar; 49(3A Suppl):104-12. PubMed ID: 9123729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostate-specific membrane antigen: current and future utility.
    Gregorakis AK; Holmes EH; Murphy GP
    Semin Urol Oncol; 1998 Feb; 16(1):2-12. PubMed ID: 9508077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of prostate specific antigen, prostate specific membrane antigen, and LNCaP-based enzyme-linked immunosorbent assays in prostatic cancer patients and patients with benign prostatic enlargement.
    Murphy GP; Holmes EH; Boynton AL; Kenny GM; Ostenson RC; Erickson SJ; Barren RJ
    Prostate; 1995 Mar; 26(3):164-8. PubMed ID: 7534919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of circulating tumor cells in patients with prostate cancer using prostate specific membrane-derived primers in the polymerase chain reaction.
    Noguchi M; Miyajima J; Itoh K; Noda S
    Int J Urol; 1997 Jul; 4(4):374-9. PubMed ID: 9256327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined nested reverse transcription-PCR assay for prostate-specific antigen and prostate-specific membrane antigen in detecting circulating prostatic cells.
    Zhang Y; Zippe CD; Van Lente F; Klein EA; Gupta MK
    Clin Cancer Res; 1997 Jul; 3(7):1215-20. PubMed ID: 9815802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced expression of prostate-specific membrane antigen gene in prostate cancer as revealed by in situ hybridization.
    Kawakami M; Nakayama J
    Cancer Res; 1997 Jun; 57(12):2321-4. PubMed ID: 9192800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of prostate-specific antigen- or prostate-specific membrane antigen-positive circulating cells in prostatic cancer patients: clinical implications.
    Millon R; Jacqmin D; Muller D; Guillot J; Eber M; Abecassis J
    Eur Urol; 1999 Oct; 36(4):278-85. PubMed ID: 10473985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of real-time quantitative PCR to detect circulating prostate-specific membrane antigen mRNA in patients with prostate carcinoma.
    Chu DC; Chuang CK; Liou YF; Tzou RD; Lee HC; Sun CF
    Ann N Y Acad Sci; 2004 Jun; 1022():157-62. PubMed ID: 15251956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sensitive nested reverse transcription polymerase chain reaction detection of circulating prostatic tumor cells: comparison of prostate-specific membrane antigen and prostate-specific antigen-based assays.
    Israeli RS; Miller WH; Su SL; Powell CT; Fair WR; Samadi DS; Huryk RF; DeBlasio A; Edwards ET; Wise GJ
    Cancer Res; 1994 Dec; 54(24):6306-10. PubMed ID: 7527294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular staging of prostate cancer. II. A comparison of the application of an enhanced reverse transcriptase polymerase chain reaction assay for prostate specific antigen versus prostate specific membrane antigen.
    Cama C; Olsson CA; Raffo AJ; Perlman H; Buttyan R; O'Toole K; McMahon D; Benson MC; Katz AE
    J Urol; 1995 May; 153(5):1373-8. PubMed ID: 7536252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measurement of serum prostate-specific membrane antigen, a new prognostic marker for prostate cancer.
    Murphy GP; Kenny GM; Ragde H; Wolfert RL; Boynton AL; Holmes EH; Misrock SL; Bartsch G; Klocker H; Pointner J; Reissigl A; McLeod DG; Douglas T; Morgan T; Gilbaugh J
    Urology; 1998 May; 51(5A Suppl):89-97. PubMed ID: 9610563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Related biomarkers in the diagnosis of prostate cancer].
    Xu YM; Liu HZ
    Zhonghua Nan Ke Xue; 2015 Oct; 21(10):937-40. PubMed ID: 26665686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification, purification, and subcellular localization of prostate-specific membrane antigen PSM' protein in the LNCaP prostatic carcinoma cell line.
    Grauer LS; Lawler KD; Marignac JL; Kumar A; Goel AS; Wolfert RL
    Cancer Res; 1998 Nov; 58(21):4787-9. PubMed ID: 9809977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.